Clin Psychopharmacol Neurosci.
2018 May;16(2):221-223. 10.9758/cpn.2018.16.2.221.
Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
- Affiliations
-
- 1Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan. zuinarita@ncnp.go.jp
- 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
- KMID: 2412393
- DOI: http://doi.org/10.9758/cpn.2018.16.2.221
Abstract
- Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Emerging of Explosive Speech after Olanzapine in Multiple System Atrophy Patient
- A Case of Very-late-onset Schizophrenia-like Psychosis
- Low Dose Olanzapine Induced Tardive Dyskinesia: A Case Report
- Delirium Associated with Olanzapine Therapy in an Elderly Male with Bipolar Affective Disorder
- Olanzapine-induced Orthostatic Hypotension
